[go: up one dir, main page]

HUE060078T2 - CDK7 gátlására alkalmas vegyületek - Google Patents

CDK7 gátlására alkalmas vegyületek

Info

Publication number
HUE060078T2
HUE060078T2 HUE18808599A HUE18808599A HUE060078T2 HU E060078 T2 HUE060078 T2 HU E060078T2 HU E18808599 A HUE18808599 A HU E18808599A HU E18808599 A HUE18808599 A HU E18808599A HU E060078 T2 HUE060078 T2 HU E060078T2
Authority
HU
Hungary
Prior art keywords
compounds capable
inhibiting cdk7
cdk7
inhibiting
compounds
Prior art date
Application number
HUE18808599A
Other languages
English (en)
Inventor
David Andrew Coates
Carlos Montero
Bharvin Kumar Rameschandra Patel
David Michael Remick
Vipin Yadav
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HUE060078T2 publication Critical patent/HUE060078T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUE18808599A 2017-11-16 2018-11-09 CDK7 gátlására alkalmas vegyületek HUE060078T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382778 2017-11-16
EP18382034 2018-01-23
EP18382546 2018-07-20

Publications (1)

Publication Number Publication Date
HUE060078T2 true HUE060078T2 (hu) 2023-01-28

Family

ID=64477309

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18808599A HUE060078T2 (hu) 2017-11-16 2018-11-09 CDK7 gátlására alkalmas vegyületek

Country Status (33)

Country Link
US (3) US10472370B2 (hu)
EP (1) EP3710446B1 (hu)
JP (1) JP6633254B2 (hu)
KR (1) KR102450727B1 (hu)
CN (1) CN111344292B (hu)
AU (1) AU2018369508B2 (hu)
BR (1) BR112020008253A2 (hu)
CA (1) CA3080910C (hu)
CL (1) CL2020001218A1 (hu)
CR (1) CR20200184A (hu)
DK (1) DK3710446T3 (hu)
DO (1) DOP2020000102A (hu)
EC (1) ECSP20025899A (hu)
ES (1) ES2925219T3 (hu)
HR (1) HRP20221152T1 (hu)
HU (1) HUE060078T2 (hu)
IL (1) IL274540B (hu)
JO (1) JOP20200122B1 (hu)
LT (1) LT3710446T (hu)
MD (1) MD3710446T2 (hu)
MX (1) MX2020004932A (hu)
MY (1) MY197700A (hu)
NZ (1) NZ763551A (hu)
PE (1) PE20210392A1 (hu)
PH (1) PH12020550792A1 (hu)
PL (1) PL3710446T3 (hu)
RS (1) RS63530B1 (hu)
SA (1) SA520411990B1 (hu)
SG (1) SG11202003677UA (hu)
SI (1) SI3710446T1 (hu)
TW (1) TWI703149B (hu)
UA (1) UA122893C2 (hu)
WO (1) WO2019099298A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015154022A1 (en) * 2014-04-05 2015-10-08 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物
IL292519A (en) * 2019-10-29 2022-06-01 Syros Pharmaceuticals Inc Methods for treating cancer in patients identified with a biomarker with cyclin-dependent kinase 7 (cdk7) inhibitors
US20230115907A1 (en) * 2019-12-20 2023-04-13 Evopoint Biosciences Co., Ltd. Heterocyclic compound and pharmaceutical composition, preparation method, intermediate and use thereof
WO2022033552A1 (zh) * 2020-08-12 2022-02-17 隆泰申医药科技(南京) 有限公司 Cdk激酶抑制剂、其制备方法、药物组合物和应用
USD987844S1 (en) 2021-08-31 2023-05-30 MerchSource, LLC Percussion massager
USD1051414S1 (en) 2021-08-31 2024-11-12 MerchSource, LLC Percussion massager
USD1079044S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1004119S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD1079041S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1078077S1 (en) 2021-08-31 2025-06-03 MerchSource, LLC Percussion massager
USD1079043S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1079042S1 (en) 2021-08-31 2025-06-10 MerchSource, LLC Percussion massager
USD1060711S1 (en) 2021-08-31 2025-02-04 MerchSource, LLC Percussion massager
USD1004117S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD1004118S1 (en) 2021-08-31 2023-11-07 MerchSource, LLC Percussion massager
USD994898S1 (en) 2021-11-17 2023-08-08 MerchSource, LLC Percussion massager
USD995812S1 (en) 2021-11-22 2023-08-15 MerchSource, LLC Percussion massager
USD1009292S1 (en) 2021-12-22 2023-12-26 MerchSource, LLC Percussion massager
USD1018881S1 (en) 2021-12-22 2024-03-19 MerchSource, LLC Percussion massager
USD1004121S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
USD1004122S1 (en) 2021-12-31 2023-11-07 MerchSource, LLC Pivoting percussion massager
CN114452391B (zh) * 2022-01-28 2023-08-25 深圳市泰尔康生物医药科技有限公司 Cdk16作为靶标在制备用于治疗三阴性乳腺癌的药物中的应用
EP4610256A1 (en) 2022-10-25 2025-09-03 Tuojie Biotech (Shanghai) Co., Ltd. Piperidinopyrimidine derivative, preparation method therefor and use thereof in medicine
WO2024125532A1 (zh) * 2022-12-12 2024-06-20 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用
WO2025040170A1 (zh) * 2023-08-24 2025-02-27 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283868T3 (es) * 2002-09-04 2007-11-01 Schering Corporation Compuestos pirazol(1,5-a) pirimidina como inhibidores de quinasa dependiente de ciclina.
GB201403093D0 (en) * 2014-02-21 2014-04-09 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2015154022A1 (en) * 2014-04-05 2015-10-08 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
EP3268000B1 (en) * 2015-03-09 2021-08-04 Aurigene Discovery Technologies Limited Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
WO2016160617A2 (en) 2015-03-27 2016-10-06 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
EP3302448B1 (en) 2015-06-04 2023-10-25 Aurigene Oncology Limited Substituted heterocyclyl derivatives as cdk inhibitors
JP7028766B2 (ja) 2015-09-09 2022-03-02 ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド サイクリン依存性キナーゼの阻害剤
TWI703149B (zh) * 2017-11-16 2020-09-01 美商美國禮來大藥廠 用於抑制cdk7之化合物

Also Published As

Publication number Publication date
CL2020001218A1 (es) 2020-08-21
DK3710446T3 (da) 2022-08-01
UA122893C2 (uk) 2021-01-13
US20210032257A1 (en) 2021-02-04
NZ763551A (en) 2021-12-24
RS63530B1 (sr) 2022-09-30
SA520411990B1 (ar) 2022-07-24
CN111344292A (zh) 2020-06-26
HRP20221152T1 (hr) 2022-11-25
TW201930305A (zh) 2019-08-01
AU2018369508B2 (en) 2021-03-11
LT3710446T (lt) 2022-09-26
WO2019099298A1 (en) 2019-05-23
MX2020004932A (es) 2020-08-27
JOP20200122B1 (ar) 2023-09-17
JP6633254B2 (ja) 2020-01-22
BR112020008253A2 (pt) 2020-11-17
MD3710446T2 (ro) 2022-12-31
ES2925219T3 (es) 2022-10-14
MY197700A (en) 2023-07-06
PE20210392A1 (es) 2021-03-02
SI3710446T1 (sl) 2022-09-30
JOP20200122A1 (ar) 2020-05-20
JP2019537616A (ja) 2019-12-26
CN111344292B (zh) 2022-06-03
AU2018369508A1 (en) 2020-05-07
US10472370B2 (en) 2019-11-12
CA3080910A1 (en) 2019-05-23
IL274540B (en) 2022-06-01
PH12020550792A1 (en) 2021-04-12
SG11202003677UA (en) 2020-05-28
PL3710446T3 (pl) 2022-10-10
CA3080910C (en) 2023-02-07
EP3710446A1 (en) 2020-09-23
ECSP20025899A (es) 2020-06-30
DOP2020000102A (es) 2020-08-31
KR20200070323A (ko) 2020-06-17
EP3710446B1 (en) 2022-07-20
US20190144456A1 (en) 2019-05-16
CR20200184A (es) 2020-06-01
US20200017513A1 (en) 2020-01-16
IL274540A (en) 2020-06-30
KR102450727B1 (ko) 2022-10-06
TWI703149B (zh) 2020-09-01
US10787460B2 (en) 2020-09-29

Similar Documents

Publication Publication Date Title
HUE060078T2 (hu) CDK7 gátlására alkalmas vegyületek
CY2024003I2 (el) Ενωσεις χρησιμες ως αναστολεις κινασης
IL263586B (en) Inhibitors of the menin-mll interaction
EP3541932A4 (en) INHIBITORS OF CRISPR-CAS9
EP3247692A4 (en) INHIBITORS OF TRKA KINASE
HRP20190407T1 (hr) Heteroarilni spojevi za inhibiciju kinaza
ME03610B (me) Naftiridinska jedinjenja kao inhibitori jak kinaze
PL3209656T3 (pl) Związki indolo-karboksyamidu użyteczne jako inhibitory kinazy
DK3442972T3 (da) Bromdomænehæmmere
EP3386590A4 (en) BICYCLIC INHIBITORS OF PAD4
HUE050842T2 (hu) Janus-kináz inhibitor
EP3609871A4 (en) ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
EP3386505A4 (en) AZA-BENZIMIDAZOLINHIBITORS OF PAD4
PL3457851T3 (pl) Pochodne sobetiromu
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
EP3556758A4 (en) CDK4 / 6-INHIBITOR
IT201700028116A1 (it) Gruppo di attuazione rotativo-lineare
IL250613B (en) Substituted bicyclic compounds
IL254502B (en) Solid forms of menaquinols
EP3661935A4 (en) SUBSTITUTED PYRAZOLOPYRIMIDINES THAT MAY BE USED AS KINASE INHIBITORS
EP3277701A4 (en) SYNTHESIS OF DESOSAMINES
MA44607A (fr) Inhibiteurs de kinase
LT3194407T (lt) Makrocikliniai rip2 kinazės inhibitoriai
DK3672941T3 (da) Pyridylpyridonforbindelser
DK3481826T3 (da) Tyrosinkinaseinhibitorer